- Rating
- 1
- Confidence
- 3
- Informativeness
- 1
- Presentation
- 2
- Soundness
- 1
Read review
Paper summary
The paper proposes SurvTabGen, a structured generative model for synthetic survival data. It combines adversarial training with a policy-gradient reward based on the discrepancy between real and synthetic Kaplan–Meier curves. Experiments show improved population-level survival-curve agreement and competitive downstream prediction.
Critical strengths
The method directly incorporates survival-curve agreement into generator training. The experiments and ablation study demonstrate that this objective improves the corresponding population-level metric.
Critical weaknesses
-
The reward is insufficiently justified for the intended use of synthetic data. The Wasserstein identity explains the marginal survival-curve objective, but does not establish that optimizing it preserves conditional survival distributions. Different subpopulations can have incorrect or reversed risk relationships while the overall survival curve remains correct. The limited subgroup evaluation does not resolve this concern.
-
The motivation for generating an entire dataset is not clearly connected to the main objective. If the intended use is only to recover one population survival curve, sharing that curve would be a simpler alternative. Synthetic data becomes useful when it supports additional analyses, such as subgroup risks or covariate–outcome relationships. The paper needs stronger evidence that its reward improves these uses beyond improving the curve it directly optimizes.
Questions for authors
-
Under what assumptions does reducing the marginal survival-curve discrepancy also control errors in subgroup or conditional survival distributions? If there is no such implication, what prevents the reward from favoring aggregate agreement at the expense of subgroup accuracy?
-
Which intended analyses require synthetic records rather than a released survival curve? For those analyses, does adding the survival reward improve accuracy compared with the same generator without that reward?
4 comments
Response to Q2: Justification for Synthetic Data and the Impact of the Reward on Downstream Utility
Q2: Justification for Synthetic Data and the Impact of the Reward on Downstream Utility
We agree that releasing a population-level Kaplan-Meier curve would be sufficient if the sole objective were to communicate aggregate survival behavior. However, the purpose of synthetic record generation is broader: to provide reusable, individual-level records that retain covariates and their relationships with event outcomes and observed times. Such records enable analyses that cannot be performed using an aggregate survival curve alone, including covariate-based risk stratification, subgroup comparisons, and training downstream survival prediction models.
We demonstrate this utility in Appendix E.7 (Table 8), where three survival models (CoxPH, SurvivalXGBoost, and Random Survival Forest) are trained on synthetic records and evaluated on held-out real data. SurvTabGen achieves an average C-index of 0.703, close to SurvDiff (0.711), and an average Brier Score of 0.134, close to the best-performing baseline, TapTap (0.126). This performance is highly competitive, falling just slightly behind the best methods by a narrow margin of 0.008 on both metrics. More importantly, SurvTabGen outperforms or remains competitive with models trained directly on the real data. These results demonstrate that SurvTabGen generates records that support downstream survival prediction, rather than merely reproducing an aggregate survival curve.
To answer the reviewer's question whether the survival reward contributes to this downstream utility, we conducted an additional ablation comparing the same generator with (no reward) and (with reward), using the downstream evaluation protocol in Appendix E.7. The results are reported below.
The survival reward improves the average C-index from 0.684 to 0.703, with improvements on six of the seven datasets and no change on Flchain. The average Brier Score also decreases from 0.190 to 0.134, although the improvement is not uniform across datasets. These results indicate that the survival reward contributes to downstream predictive performance.
C-index (, higher is better)
| Dataset | SurvTabGen () | SurvTabGen () |
|---|---|---|
| AIDS | 0.697 (0.05) | 0.707 (0.05) |
| Cgvhd | 0.500 (0.00) | 0.551 (0.09) |
| Flchain | 0.929 (0.00) | 0.929 (0.00) |
| Gbsg2 | 0.638 (0.02) | 0.656 (0.02) |
| Veterans | 0.605 (0.09) | 0.641 (0.03) |
| Whas500 | 0.721 (0.03) | 0.728 (0.01) |
| AM | 0.700 (0.04) | 0.711 (0.05) |
| Average | 0.684 | 0.703 |
Brier Score (, lower is better)
| Dataset | SurvTabGen () | SurvTabGen () |
|---|---|---|
| AIDS | 0.068 (0.01) | 0.061 (0.00) |
| Cgvhd | 0.515 (0.20) | 0.129 (0.02) |
| Flchain | 0.050 (0.00) | 0.050 (0.00) |
| Gbsg2 | 0.269 (0.01) | 0.272 (0.01) |
| Veterans | 0.162 (0.04) | 0.144 (0.03) |
| Whas500 | 0.194 (0.01) | 0.199 (0.01) |
| AM | 0.077 (0.01) | 0.083 (0.01) |
| Average | 0.190 | 0.134 |
We hope these new empirical results address your concerns, and we kindly ask that you reconsider your evaluation.
Dear Reviewer dwVA,
As the Author/Reviewer discussion period concludes today, Nov. 18, we want to follow up to see if our rebuttal has successfully resolved your concerns.
We would be happy to answer any remaining questions.
If our responses have addressed your points, we would be grateful if you considered reflecting this in your overall evaluation.
Thank you again for your time and constructive feedback.
Best regards,
The Authors
Thank you for the careful response and the additional ablation, which I appreciate. I am afraid my main concern is not yet fully resolved. Since the overall survival curve can be obtained directly from the real data, I am still unsure why the generator should be rewarded for matching it, and I could not find clear evidence in the response that this reward helps the uses that need synthetic records, such as subgroup and covariate-outcome analysis, rather than trading them off. I would therefore like to keep my score for now.
Response to Q1: Marginal Survival Curve vs. Subgroup-Conditional Distributions
We sincerely thank Reviewer dwVA for the thoughtful and technically insightful feedback. We respond to your two questions below.
Q1: Marginal Survival Curve vs. Subgroup-Conditional Distributions
First, while preserving survival patterns across subpopulations is important, subgroup definitions are application-dependent and often require domain expert input to ensure clinical or practical relevance. Because meaningful subgroups vary widely across the seven diverse clinical and industrial datasets evaluated in this work, a unified subgroup evaluation protocol does not exist. Our main objective is therefore to preserve the global survival curve on the whole population, aligning with the objective of other state-of-the-art methods such as SurvivalGAN, Ashhad, and SurvDiff.
Second, we agree that minimizing the marginal survival-curve discrepancy (IAD) does not, by itself, theoretically guarantee preservation of subgroup-conditional survival distributions. However, the survival reward is not the sole component of SurvTabGen's training objective. Our generator jointly optimizes LG=Ladv+λLsurv. The adversarial objective operates on the complete generated records (X,E,T), encouraging the synthetic joint distribution to match the real joint distribution. In addition, our dependency-aware architecture generates event indicators conditioned on covariates and survival times conditioned on both covariates and event indicators. Thus, the adversarial objective and conditional generation architecture complement the marginal survival reward by encouraging preservation of covariate-outcome dependencies.
In particular, at the population level, exact matching of the joint distribution would imply matching conditional distributions almost everywhere on the support of the covariates. Although finite-sample adversarial training does not guarantee exact matching or provide a formal bound on subgroup errors, it discourages solutions that reproduce the global survival curve while substantially distorting covariate-outcome relationships.
Finally, we also provide empirical subgroup-level evidence in Appendix E.2 (Table 5). On the Whas500 dataset, SurvTabGen achieves the lowest KM Divergence for the overall population (0.035), as well as the Elderly (0.076) and Very Elderly (0.079) cohorts. SurvivalGAN performs best for the Young cohort (0.063), while SurvTabGen obtains 0.131. While we acknowledge that subgroup preservation is not uniformly superior across all cohorts, these results provide evidence that optimizing the global survival objective can be compatible with preserving subgroup-specific survival patterns.